Evidence map›Paper›PMID 41283455›Full record

ArticleGeriatrics (Basel, Switzerland)2025

Clinical Inertia in SGLT2 Inhibitor Use Among Elderly Patients with Type 2 Diabetes and Chronic Kidney Disease: A Comparison of Regional and University Hospital Practice.

Kyriaki Vafeidou, Ourania Psoma, Evangelos Apostolidis, Anastasia Sarvani, Michael Doumas, Kalliopi Kotsa, Vasileios Tsimihodimos, Theocharis Koufakis

Abstract read
In one paragraph

Article in Geriatrics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Hypertension in Diabetes: Numbers or Outcomes?American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kyriaki VafeidouSchool of Medicine, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
Ourania PsomaSchool of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Evangelos ApostolidisSchool of Medicine, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
Anastasia SarvaniSchool of Medicine, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
Michael DoumasSchool of Medicine, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
Kalliopi KotsaSchool of Medicine, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.ORCID 0000-0003-2376-740X
Vasileios TsimihodimosSchool of Medicine, University of Ioannina, 45110 Ioannina, Greece.ORCID 0000-0003-1708-3415
Theocharis KoufakisSchool of Medicine, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.ORCID 0000-0002-5853-1352

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic kidney diseaseclinical inertiaelderly patientsSGLT2 inhibitorstype 2 diabetes

Identifiers

PMID41283455
PMCPMC12641619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.